Medplus Health Services DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.79×	0.80×	0.82×	0.89×	1.06×
	0.83×	0.85×	0.77×	0.57×	0.56×
	4.2%	4.7%	3.9%	2.3%	1.8%
	1.89×	1.89×	1.93×	1.94×	1.69×
	2.03×	1.99×	1.93×	1.90×	1.88×
	10.7%	12.0%	9.1%	4.3%	3.5%
	11.8%	11.8%	9.1%	4.3%	3.4%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

MEDPLUS₹595.00

Medplus Health Services Ltd.

· Consumer Services

₹ CrorePeersAPOLLOHOSP MANYAVAR MSTCLTD NESCO JUSTDIAL JSLL QUESS IXIGOMcap ₹7,143 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	1.06	0.89	0.82	0.80	0.79
Interest Burden (Pretax/EBIT) ×	0.56	0.57	0.77	0.85	0.83
EBIT Margin %	1.85	2.31	3.87	4.71	4.23
Asset Turnover ×	1.69	1.94	1.93	1.89	1.89
Financial Leverage (Assets/Equity) ×	1.88	1.90	1.93	1.99	2.03
ROE (5-step product, year-end total equity) %	3.49	4.31	9.13	11.99	10.67
ROE (owners' profit / average owners' equity) %	3.42	4.27	9.06	11.82	11.82

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.